Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Mayes

Optometrist Silverdale, WA Doctor of Optometry

NPI 1073687562 CMS profile 139901

3647 Nw Byron St, Silverdale, WA 98383

Open in the dashboard

General payments

$5,709

79 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Mayes of Silverdale, WA is reported in the CMS Open Payments database as having received $5,709 across 79 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,922 25
2024 General $2,041 12
2023 General $195 5
2022 General $59 3
2021 General $249 17
2020 General $115 8
2019 General $129 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Mayes
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to John Mayes were reported at $2,922. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year John Mayes Optometrist median Middle half National median
2019 $129 $159 $67–$371 $163
2020 $115 $72 $29–$165 $114
2021 $249 $125 $46–$292 $132
2022 $59 $162 $66–$374 $149
2023 $195 $177 $72–$406 $160
2024 $2,041 $188 $77–$427 $164
2025 $2,922 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lumenis BE inc $4,083 3 payments
  2. Alcon Vision LLC $959 58 payments
  3. Mallinckrodt Hospital Products Inc. $173 4 payments
  4. Sun Pharmaceutical Industries Inc. $151 2 payments
  5. CooperVision Inc. $89 3 payments
  6. Johnson & Johnson Vision Care, Inc. $88 3 payments
  7. Oyster Point Pharma, Inc. $62 2 payments
  8. Bausch & Lomb Americas Inc. $53 2 payments
  9. Dompe US, Inc. $35 1 payment
  10. Tarsus Pharmaceuticals, Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,709 79 payments
Products named General payments · program years 2019–2025
  1. optilight $2,176 1 payment
  2. M22 $1,907 2 payments
  3. Precision 1 $310 25 payments
  4. DAILIES TOTAL1 $217 11 payments
  5. TOTAL30 $203 12 payments
  6. ACTHAR $173 4 payments
  7. Cequa $151 2 payments
  8. DAILIES $106 6 payments
  9. Clareon $87 1 payment
  10. TYRVAYA $62 2 payments
  11. Other $321 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$32,255

Medicare's payments for the services billed

Medicare patients

274

Average age 74

Services billed

412

161 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 57%
Arthritis 43%
Diabetes 26%
Atrial fibrillation 16%
Ischemic heart disease 14%
Chronic kidney disease 13%
Osteoporosis 13%
Cancer 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

79 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record